![]() |
Basic Information |
![]() |
Post buying leads |
![]() |
Suppliers |
Name |
Barium chloride |
EINECS | 233-788-1 |
CAS No. | 10361-37-2 | Density | 3.856 g/cm3 |
PSA | 0.00000 | LogP | 1.37900 |
Solubility | soluble in methanol; insoluble in ethanol, ethyl acetate | Melting Point |
962 °C |
Formula | BaCl2 | Boiling Point | 1560oC |
Molecular Weight | 244.267 | Flash Point | N/A |
Transport Information | UN 1564 6.1/PG 2 | Appearance | white crystalline powder |
Safety | 45-36-26-36/37/39 | Risk Codes | 22-25-20-36/37/38-36/38 |
Molecular Structure |
|
Hazard Symbols |
![]() ![]() ![]() |
Synonyms |
Barium dichloride;HSDB 2633;NSC 146181;NCI-C61074;Ba 0108E;CCRIS 2286;SBA 0108E;UNII-0VK51DA1T2; |
Conditions | Yield |
---|---|
In not given addition of HCl to a barium zincate-lye ppts. Zn(OH)2; filtration of Zn(OH)2; evaporation of the filtrate under obtaining of BaCl2*2H2O;; | A 90% B >99 |
In not given addition of HCl to a barium zincate-lye ppts. Zn(OH)2; filtration of Zn(OH)2; evaporation of the filtrate under obtaining of BaCl2*2H2O;; | A 90% B >99 |
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
With H2O In neat (no solvent, gas phase) Kinetics; |
Conditions | Yield |
---|---|
In hydrogenchloride reaction of BaCO3 with HCl forms BaCl2*2H2O;; product contains 98-99%;; |
Conditions | Yield |
---|---|
In not given byproducts: S; passing of SO2 in a BaS-solution ppts. BaS2O3; BaS2O3 reacts with HCl under formation of BaCl2; filtration of the pptd. S; crystallisation of BaCl2*2H2O out of the filtrate;; |
Conditions | Yield |
---|---|
In neat (no solvent) treatment of CaS with an acidic mother-lye; addition of gaseous HCl to the solution under pptn. of BaCl2*2H2O;; washing with H2O or dild. BaS-solution;; | |
In water addition of HCl to a BaS-solution until pH 5; neutralisation with addition of BaS-solution; filtration; evaporation of the solution; vac.-crystallisation forms BaCl2*2H2O;; | |
In neat (no solvent) treatment of CaS with an acidic mother-lye; addition of concd. HCl to the solution under pptn. of BaCl2*2H2O;; washing with H2O or dild. BaS-solution;; |
magnesium chloride
B
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
In not given reaction of BaS-solutions with MgCl2-solution ppts. Mg(OH)2; filtration; crystallisation of BaCl2*2H2O out of the solution;; repptn.;; |
hydrogenchloride
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
In diethyl ether extraction of irridiated UO2(NO3)2*nH2O with ether; the formed aq. solution contains all decomposition products; seperation of the aq. solution; addition of BaCl2; pptn. of BaCl2*2H2O with 37% aq. HCl;; twice repptn.;; |
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
In water pptn. (HCl); | |
In water pptn. out of concd. aq. BaCl2-solution with addition of alcohol;; | |
In water pptn. (HCl); |
hydrogenchloride
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
In hydrogenchloride solving of irridiated (NH4)2U2O7 in 25% aq. HCl; addition of BaCl2 in a small amount of H2O; pptn. of BaCl2*2H2O with 37% aq. HCl; filtration on hardened filter;; washing of the ppt. with 25% aq. HCl; washing with alcohol;; |
chlorine
B
barium(II) chloride dihydrate
Conditions | Yield |
---|---|
with dry chlorine; product with 29.93% active chlorine content; | |
with dry chlorine; product with 29.93% active chlorine content; |
Reported in EPA TSCA Inventory. Barium chloride (CAS NO.10361-37-2) and its compounds are on the Community Right-To-Know List. EPA Genetic Toxicology Program.
OSHA PEL: TWA 0.5 mg(Ba)/m3
ACGIH TLV: TWA 0.5 mg(Ba)/m3; Not Classifiable as a Human Carcinogen
DFG MAK: 0.5 mg(Ba)/m3
Barium chloride is the ionic chemical compound with the formula BaCl2. The substance has the CAS register number 10361-37-2 and EINECS number 233-788-1. It is stable, but incompatible with other materials like bromine trifluoride and furan-2-peroxycarboxylic acid. Barium chloride anhydrous is a white solid. Any of a variety of substances that contain barium. Most are whitish colored crystalline solids. They tend to be soluble in water and denser than water. They may be toxic by inhalation or possibly skin absorption.Barium chloride anhydrous is non-combustible. The substance itself does not burn but may decompose upon heating to produce corrosive and toxic fumes. Some are oxidizers and may ignite combustibles (wood, paper, oil, clothing, etc.). Contact with metals may evolve flammable hydrogen gas. In additionm, when heated, its container may explode.
Properties of Barium chloride:
Barium chloride anhydrous may react violently with BrF3 and 2-furan percarboxylic acid in its anhydrous form. Barium chloride can react with sulfate ion to generate a thick white precipitate of barium sulfate. Moreover, it can react with oxalate to give barium oxalate. The reaction equations are as the follwing:
Ba2+(aq) + SO42-(aq) → BaSO4(s)
Ba2+(aq) + C2O42-(aq) → BaC2O4(s)
Preparation of Barium chloride:
Barium chloride anhydrous is produced by barium hydroxide or barium carbonate. And then Barium chloride anhydrous reactS with hydrochloric acid to give hydrated barium chloride. In industry, it is prepared via a two step process from barium sulfate at high temperature. Afterward, The second step requires fusion of the reactants. The Barium chloride can then be leached out from the mixture with water.
BaSO4 + 4 C → BaS + 4 CO
BaS + CaCl2 → BaCl2 + CaS
In addition, Barium chloride can also be prepared by heating Barium chloride dihydrate at 125 °C. The reaction equation is as following:
BaCl2.2 H2O → BaCl2 +2 H2O
Uses of Barium Barium chloride:
Because it is a cheap and soluble salt of barium, Barium chloride anhydrous is widely used in the laboratory. In industry, Barium chloride anhydrous is mainly used in the purification of brine solution in caustic chlorine plants and also in the manufacture of heat treatment salts, case hardening of steel, in the manufacture of pigments and other barium salts. It is commonly used as a test for sulfate ion. Barium chloride anhydrous is also used in fireworks to give a bright green color.
Safety information of Barium chloride:
When you are using Barium chloride anhydrous, you should be very cautious about it. It is toxic if swallowed and harmful by inhalation. In case of accident or if you feel unwell seek medical advice immediately (show the label where possible).
Descriptors computed from structure of Barium chloride anhydrous:
(1)Canonical SMILES: [Cl-].[Cl-].[Ba+2]
(2)InChI: InChI=1S/Ba.2ClH/h;2*1H/q+2;;/p-2
(3)InChIKey: WDIHJSXYQDMJHN-UHFFFAOYSA-L
The toxicity of Barium chloride:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | intravenous | 40mg/kg (40mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
cat | LDLo | subcutaneous | 18mg/kg (18mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
dog | LD50 | unreported | 90mg/kg (90mg/kg) | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. | |
dog | LDLo | oral | 90mg/kg (90mg/kg) | "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 53, 1973. | |
dog | LDLo | subcutaneous | 10mg/kg (10mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
domestic animals - goat/sheep | LDLo | parenteral | 7mg/kg (7mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: MUSCLE WEAKNESS | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. |
frog | LDLo | subcutaneous | 910mg/kg (910mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
guinea pig | LD50 | oral | 76mg/kg (76mg/kg) | Food Research. Vol. 7, Pg. 313, 1942. | |
guinea pig | LDLo | subcutaneous | 55mg/kg (55mg/kg) | "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 53, 1973. | |
horse/donkey | LD50 | unreported | 800mg/kg (800mg/kg) | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. | |
mammal (species unspecified) | LD50 | oral | 398mg/kg (398mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: MUSCLE WEAKNESS GASTROINTESTINAL: NAUSEA OR VOMITING | Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 28(6), Pg. 45, 1984. |
mouse | LD50 | intraperitoneal | 39mg/kg (39mg/kg) | Farmakologiya i Toksikologiya Vol. 10, Pg. 107, 1975. | |
mouse | LD50 | intravenous | 12mg/kg (12mg/kg) | Toxicology and Applied Pharmacology. Vol. 22, Pg. 150, 1972. | |
mouse | LD50 | unreported | 7mg/kg (7mg/kg) | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. | |
mouse | LDLo | oral | 70mg/kg (70mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
mouse | LDLo | subcutaneous | 10mg/kg (10mg/kg) | National Technical Information Service. Vol. AEC-TR-6710, | |
rabbit | LD50 | unreported | 170mg/kg (170mg/kg) | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. | |
rabbit | LDLo | intravenous | 15mg/kg (15mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
rabbit | LDLo | oral | 170mg/kg (170mg/kg) | "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 53, 1973. | |
rabbit | LDLo | parenteral | 20mg/kg (20mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED | Medicina del Lavoro. Industrial Medicine. Vol. 30, Pg. 44, 1939. |
rabbit | LDLo | subcutaneous | 40mg/kg (40mg/kg) | Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975. | |
rat | LD50 | oral | 118mg/kg (118mg/kg) | Food Research. Vol. 7, Pg. 313, 1942. | |
rat | LD50 | subcutaneous | 178mg/kg (178mg/kg) | "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 53, 1973. | |
rat | LD50 | unreported | 150mg/kg (150mg/kg) | New Zealand Veterinary Journal. Vol. 47, Pg. 150, 1999. | |
rat | LDLo | intravenous | 20mg/kg (20mg/kg) | BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Journal of Laboratory and Clinical Medicine. Vol. 15, Pg. 35, 1929. |